CELLULAR-DISTRIBUTION OF ANGIOTENSIN-CONVERTING ENZYME AFTER MYOCARDIAL-INFARCTION

被引:144
作者
FALKENHAHN, M
FRANKE, F
BOHLE, RM
ZHU, YC
STAUSS, HM
BACHMANN, S
DANILOV, S
UNGER, T
机构
[1] UNIV GIESSEN,DEPT PATHOL,GIESSEN,GERMANY
[2] UNIV HEIDELBERG,DEPT ANAT & CELL BIOL,HEIDELBERG,GERMANY
[3] NATL CARDIOL RES CTR,MOSCOW,RUSSIA
关键词
ANGIOTENSIN-CONVERTING ENZYME; HEART; MYOCARDIAL INFARCTION; ENDOTHELIUM; MACROPHAGES;
D O I
10.1161/01.HYP.25.2.219
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We studied the cellular distribution of angiotensin-converting enzyme (ACE) in the heart related to the cell types involved in left ventricular repair and remodeling before and after myocardial infarction by immunohistochemical techniques using monoclonal and polyclonal antibodies. In noninfarcted myocardium of both human and rat, ACE expression was confined to endothelial cells and subendocardial cell layers of the aortic valve. ACE was prominent in endothelia of small arteries and arterioles, whereas only half the coronary capillaries were immunoreactive and venous vessels were almost completely devoid of the enzyme. In a rat model of myocardial infarction, ACE distribution was determined 1, 3, and 7 days and 2, 3, and 6 weeks after coronary occlusion. Three and 7 days after infarction, endothelial cells of sprouting capillaries and macrophages in the marginal zone of necrosis revealed ACE expression. In both human and rat with the onset of fibrosis, intense staining of the enzyme was found in the marginal zone of the repair tissue. In situ hybridization for collagen type I in the rat revealed that zones with high collagen content had almost no ACE immunoreactivity. Vascular smooth muscle cells and cardiomyocytes revealed no ACE expression throughout the study. We conclude that endothelial cells are the principal source for the expression of ACE after myocardial infarction. The observed induction of ACE with the onset of fibrosis suggests a role of this enzyme that is related to tissue repair and remodeling.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 46 条
  • [11] FOO ITH, 1992, LAB INVEST, V67, P727
  • [12] ANGIOTENSIN-CONVERTING ENZYME-INHIBITION IMPROVES CARDIAC-FUNCTION - ROLE OF BRADYKININ
    GOHLKE, P
    LINZ, W
    SCHOLKENS, BA
    KUWER, I
    BARTENBACH, S
    SCHNELL, A
    UNGER, T
    [J]. HYPERTENSION, 1994, 23 (04) : 411 - 418
  • [13] IDENTIFICATION OF POSITIVE AND NEGATIVE TRANSCRIPTIONAL REGULATORY ELEMENTS OF THE RABBIT ANGIOTENSIN-CONVERTING ENZYME GENE
    GORAYA, TY
    KESSLER, SP
    KUMAR, RS
    DOUGLAS, J
    SEN, GC
    [J]. NUCLEIC ACIDS RESEARCH, 1994, 22 (07) : 1194 - 1201
  • [14] HASHIMOTO K, 1977, JPN HEART J, V18, P679
  • [15] ANGIOTENSIN CONVERTASE ACTIVITIES IN HUMAN ALVEOLAR MACROPHAGES - EFFECTS OF CIGARETTE-SMOKING AND SARCOIDOSIS
    HINMAN, LM
    STEVENS, C
    MATTHAY, RA
    GEE, JBL
    [J]. SCIENCE, 1979, 205 (4402) : 202 - 203
  • [16] TISSUE-SPECIFIC ACTIVATION OF CARDIAC ANGIOTENSIN CONVERTING ENZYME IN EXPERIMENTAL HEART-FAILURE
    HIRSCH, AT
    TALSNESS, CE
    SCHUNKERT, H
    PAUL, M
    DZAU, VJ
    [J]. CIRCULATION RESEARCH, 1991, 69 (02) : 475 - 482
  • [17] EXPERIMENTAL MYOCARDIAL INFARCTION .1. A METHOD OF CORONARY OCCLUSION IN SMALL ANIMALS
    JOHNS, TNP
    OLSON, BJ
    [J]. ANNALS OF SURGERY, 1954, 140 (05) : 675 - 682
  • [18] CHANGES IN CARDIAC ANGIOTENSIN CONVERTING ENZYME AFTER MYOCARDIAL-INFARCTION AND HYPERTROPHY IN RATS
    JOHNSTON, CI
    MOOSER, V
    SUN, Y
    FABRIS, B
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1991, 18 (02) : 107 - 110
  • [19] SERUM ANGIOTENSIN-1 CONVERTING ENZYME-ACTIVITY PROCESSES A HUMAN IMMUNODEFICIENCY VIRUS-1 GP160 PEPTIDE FOR PRESENTATION BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES
    KOZLOWSKI, S
    CORR, M
    TAKESHITA, T
    BOYD, LF
    PENDLETON, CD
    GERMAIN, RN
    BERZOFSKY, JA
    MARGULIES, DH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) : 1417 - 1422
  • [20] KUMAR RS, 1991, J BIOL CHEM, V266, P3854